Extract

The objective of this trial is to evaluate the efficacy and safety of two different treatment regimens with BI 201335, both in combination with PegIFN/RBV) as compared to standard of care (SOC) with PegIFN/RBV alone.

Inclusion criteria

• Hepatitis C

Country

• Austria
• Belgium
• France
• Germany
• Japan
• Portugal
• Romania
• Russian Federation
• Spain
• Switzerland
• United Kingdom

Links

• ictrp
• nct